ITX-5061
- Generic Name
- ITX-5061
Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection
- First Posted Date
- 2012-03-22
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Schiano, Thomas D., MD
- Target Recruit Count
- 10
- Registration Number
- NCT01560468
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients
- First Posted Date
- 2011-02-10
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- University of Birmingham
- Target Recruit Count
- 24
- Registration Number
- NCT01292824
- Locations
- 🇬🇧
University Hospital Birmingham, Birmingham, West Midlands, United Kingdom
Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected Adults
- First Posted Date
- 2010-07-19
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 30
- Registration Number
- NCT01165359
- Locations
- 🇺🇸
Alabama Therapeutics CRS, Birmingham, Alabama, United States
🇺🇸Ucsd, Avrc Crs, San Diego, California, United States
🇺🇸Univ. of Cincinnati CRS, Cincinnati, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath